ICAM3 significantly increased under hypoglycemia and at 24 h post hypoglycemia in the combined cohort, but compared to controls, T2D subjects had decreased levels at 2 and 24 h post hypoglycemia, suggesting endothelial dysfunction that differs between those with T2D and those without T2D. Here, ICAM3 is linked to endothelial dysfunction.